Literature DB >> 15935118

Lower Extremity Arterial Occlusive Disease: Role of Percutaneous Revascularization.

Ronak S Kanani1, Joseph M Garasic.   

Abstract

Percutaneous endovascular interventions for peripheral arterial disease are indicated in carefully selected patients with favorable anatomy and associated clinical symptoms. Although endovascular therapy appears to be hemodynamically equivalent to other modalities in isolated iliac disease, this does not appear to be the case for infrainguinal disease, particularly when the disease is diffuse and extensive. Such disease in these beds can often be treated surgically, although there is an increasing role for percutaneous therapies, particularly in patients at higher surgical risk. Catheter-based therapy should be considered an integral part of comprehensive medical therapy in patients with lower extremity peripheral arterial disease. Embarking on an endovascular approach to therapy should involve a frank physician-patient discussion of the risks, benefits, and durability of the proposed procedure tailored to anatomic locale and patient-specific factors.

Entities:  

Year:  2005        PMID: 15935118     DOI: 10.1007/s11936-005-0011-5

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  53 in total

1.  Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis. Report of a prospective randomized trial in a selected group of patients.

Authors:  S E Wilson; G L Wolf; A P Cross
Journal:  J Vasc Surg       Date:  1989-01       Impact factor: 4.268

2.  Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study.

Authors:  D Vroegindeweij; L D Vos; A V Tielbeek; J Buth; H C vd Bosch
Journal:  Cardiovasc Intervent Radiol       Date:  1997 Nov-Dec       Impact factor: 2.740

3.  Cryoplasty for femoropopliteal arterial disease: late angiographic results of initial human experience.

Authors:  Mario Fava; Soledad Loyola; Antonios Polydorou; Prodromos Papapavlou; Adamandia Polydorou; Oscar Mendiz; James D Joye
Journal:  J Vasc Interv Radiol       Date:  2004-11       Impact factor: 3.464

4.  Treatment of chronic iliac artery occlusions with guide wire recanalization and primary stent placement.

Authors:  R Reyes; M Maynar; J Lopera; H Ferral; E Gorriz; J Carreira; W R Castaneda
Journal:  J Vasc Interv Radiol       Date:  1997 Nov-Dec       Impact factor: 3.464

5.  Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study.

Authors:  Jean-Pierre Becquemin; Jean-Pierre Favre; Jean Marzelle; Chantal Nemoz; Caroline Corsin; Alain Leizorovicz
Journal:  J Vasc Surg       Date:  2003-03       Impact factor: 4.268

6.  Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3-year follow-up.

Authors:  P J Matsi; H I Manninen; R L Vanninen; M T Suhonen; I Oksala; M Laakso; T Hakkarainen; S Soimakallio
Journal:  Radiology       Date:  1994-06       Impact factor: 11.105

7.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

Review 8.  Evaluation of patients with peripheral vascular disease.

Authors:  Jonathan L Halperin
Journal:  Thromb Res       Date:  2002-06-01       Impact factor: 3.944

9.  Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group.

Authors:  E Tetteroo; Y van der Graaf; J L Bosch; A D van Engelen; M G Hunink; B C Eikelboom; W P Mali
Journal:  Lancet       Date:  1998-04-18       Impact factor: 79.321

10.  Risks and benefits of femoropopliteal percutaneous balloon angioplasty.

Authors:  M G Hunink; M C Donaldson; M F Meyerovitz; J F Polak; A D Whittemore; K Kandarpa; C J Grassi; J Aruny; D P Harrington; J A Mannick
Journal:  J Vasc Surg       Date:  1993-01       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.